Uncategorized

Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push

Published

on

An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version